Catherine M. Szyman - 07 May 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 07 May 2024
Net transactions value: -$51,820
Form type: 4
Filing time: 09 May 2024, 19:36:52 UTC
Previous filing: 06 May 2024
Next filing: 13 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+32,025	+70%	$0.000000	77,601	07 May 2024	Direct	F1
transaction	EW	Common Stock	Tax liability	$51,820	-609	-0.78%	$85.09	76,992	07 May 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.